| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $792.3M | +5.6% |
| R&D Expense | $123.7M | -8.9% |
| SG&A Expense | $117.9M | -6.1% |
| Operating Income | $65.8M | +343.8% |
| Pre-tax Income | $31.5M | +156.6% |
| Income Tax | $15.1M | +132.3% |
| Net Income | $16.4M | +284.8% |
| EPS (Basic) | $0.04 | +300.0% |
| EPS (Diluted) | $0.04 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $448.3M | -33.3% |
| Accounts Receivable | $145.9M | +1.6% |
| Current Assets | $659.3M | -24.5% |
| Total Assets | $1.39B | -12.6% |
| Current Liabilities | $123.9M | +1.1% |
| Long-term Debt | $500.0M | -22.8% |
| Total Liabilities | $663.4M | -19.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $183.9M | +33.0% |
| Capital Expenditures | $1.2M | +18.9% |
| Investing Cash Flow | -$70.3M | -26.1% |
| Financing Cash Flow | -$337.5M | -101.6% |
| Free Cash Flow | $182.7M | +33.1% |
| +300.0% |
| Stockholders' Equity |
| $724.7M |
| -4.9% |